New JPMA President Urges Permanent Installment Of New Drug Price Incentives
This article was originally published in PharmAsia News
Executive Summary
Isao Teshirogi, the new president of Japan Pharmaceutical Manufacturers Association said he will concentrate on full implementation and perpetuation of a price incentive scheme for new drug development and off-label drug use